Patents by Inventor John J. Taggart

John J. Taggart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,5- disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
    Publication number: 20030100756
    Abstract: Novel substituted pyrimido[4,5-d]pyrimidin-2-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: August 28, 2002
    Publication date: May 29, 2003
    Inventors: Jerry L Adams, Jeffrey C Boehm, John J Taggart, Ralph F Hall
  • Water soluble camptothecin analogs
    Patent number: 6046209
    Abstract: The present invention provides water soluble camptothecin analogs of Formula I: ##STR1## which are particularly useful as antineoplastic agents; pharmaceutical compositions thereof; and a method of treating cancer in an animal in need thereof, including human beings, comprising inhibition of the growth of tumor cells in said animal by administration of an effective amount of a compound of Formula I.
    Type: Grant
    Filed: January 28, 1998
    Date of Patent: April 4, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: David A. Berges, John J. Taggart
  • Water soluble camptothecin analogs
    Patent number: 5670500
    Abstract: The present invention provides water soluble camptothecin analogs of Formula I: ##STR1## which are particularly useful as antineoplastic agents; pharmaceutical compositions thereof; and a method of treating cancer in an animal in need thereof, including human beings, comprising inhibition of the growth of tumor cells in said animal by administration of an effective amount of a compound of Formula I.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: September 23, 1997
    Assignee: SmithKline Beecham Corporation
    Inventors: David A. Berges, John J. Taggart
  • Water soluble camptothecin analogs
    Patent number: 5663177
    Abstract: The present invention provides a water soluble camptothecin analog of Formula I: ##STR1## which is particularly useful as an antineoplastic agent; pharmaceutical compositions thereof; and a method of treating cancer in an animal in need thereof, including human beings, comprising inhibition of the growth of tumor cells in said animal by administration of an effective amount of a compound of Formula I.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: September 2, 1997
    Assignee: SmithKline Beecham Corporation
    Inventors: David A. Berges, John J. Taggart